Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy-Reference-Cited by-同舟云学术

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Published:2013-05-17 Issue:1 Volume:8 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Manapov Farkhad,Sepe Susanna,Niyazi Maximilian,Belka Claus,Friedel Godehard,Budach Wilfried

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-8-122.pdf

Reference14 articles.

1. Pignon JP, Stewart LA: Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis. Cancer 1996,77(11):2413-2414. 10.1002/(SICI)1097-0142(19960601)77:11<2413::AID-CNCR34>3.0.CO;2-Y

2. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M: Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 1999,52(2):137-148. 10.1016/S0167-8140(99)00087-0

3. Turrisi AT 3rd, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, Wagner H, Aisner S, Johnson DH: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999,340(40):265-271.

4. Curran WJ Jr, Paulus R, Langer CJ Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD: Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011,103(19):1452-1460. 10.1093/jnci/djr325

5. Friedel G, Hruska D, Budach W, Wolf M, Kyriss T, Hurtgen M, Eulenbruch HP, Dierkesmann R, Toomes H: Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer. Lung Cancer 2000,30(3):175-185. 10.1016/S0169-5002(00)00151-3

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese clinical practice guidelines for the prevention and treatment of radiation‐induced esophagitis;Precision Radiation Oncology;2023-09-20

2. Esophagus Inflammatory Conditions;Gastrointestinal Pathology;2021-04-30

3. Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation;Clinical and Translational Radiation Oncology;2020-05

4. Analysis of Radiation Doses and Dose Reduction Strategies During Cerebral Digital Subtraction Angiography;World Neurosurgery;2017-04

5. Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review;Current Medical Research and Opinion;2016-07-20